In addition, a significant increase was observed in the proportions of Ki67+ BTLA-positive and Ki67+ BTLA-negative T cells in CLL patients compared to the corresponding cells in HC (p = 0.02 and p = 0.0015, respectively) (Table 2, Figure 3b,c). The gene discussed is BTLA; the disease is B-cell chronic lymphocytic leukemia.